Rep. Tom Price Purchases Discounted Healthcare Stocks While Drafting Industry Legislation

On August 31, 2016, Rep. Tom Price (R-GA), chairman of the House Budget Committee and member of the Ways and Means Health Subcommittee, purchased between $50,001 and $100,000 in discounted shares of Innate Immunotherapeutics, an Australian biotech company, through a private placement offering …